Regenerative Aesthetics: Exosomes, PRP & the Future of Anti-Aging

Quick Answer: Regenerative aesthetics represents a paradigm shift from masking aging to reversing it at the cellular level. Platelet-rich plasma (PRP), exosome therapy, and polynucleotides are the three pillars of this movement, using your body's own biological signaling mechanisms -- growth factors, extracellular vesicles, and DNA fragments -- to stimulate collagen production, accelerate tissue repair, and restore youthful skin quality. Clinical studies show measurable improvements in skin elasticity, wrinkle depth, hydration, and pigmentation, with exosome-enhanced microneedling outperforming microneedling alone. While PRP is well-established, exosomes remain in regulatory limbo with no FDA-approved products yet, making provider selection and product sourcing critical.

The aesthetic medicine industry is undergoing its most significant philosophical transformation in decades. For years, the dominant approach to anti-aging has been architectural: fillers to add volume, neurotoxins to freeze muscles, lasers to resurface texture. These treatments work, but they work by altering structure or suppressing function rather than by restoring the skin's fundamental biological capacity to renew itself.

Regenerative aesthetics inverts this model. Instead of adding synthetic materials or ablating tissue, regenerative treatments harness the body's own repair mechanisms -- growth factors, stem cell-derived signaling molecules, and DNA-based compounds -- to coax aging cells into behaving more like their younger counterparts. The result is not a face that looks "done" but skin that genuinely functions better: producing more collagen, turning over more efficiently, and maintaining hydration and elasticity through restored biological pathways.

This is not theoretical. In 2026, regenerative aesthetics represents one of the fastest-growing and most scientifically substantiated frontiers in cosmetic dermatology, with PRP, exosomes, and polynucleotides leading the charge [1].

The Science of Cellular Aging and Why It Matters

To appreciate what regenerative aesthetics accomplishes, it is essential to understand what happens to skin as it ages at the cellular level.

Collagen Degradation

Collagen, the structural protein that gives skin its firmness and elasticity, begins declining at approximately 1% per year after age 20. By age 50, most people have lost roughly 30% of their dermal collagen. This loss manifests as wrinkles, sagging, thinning skin, and diminished wound-healing capacity. But the cells that produce collagen -- fibroblasts -- are still present. They simply become less active over time, receiving fewer growth factor signals and producing lower quantities of structural proteins.

Cellular Communication Breakdown

Young skin is a bustling network of cellular communication. Cells constantly send and receive signaling molecules that coordinate repair, regeneration, and maintenance. As skin ages, this communication network degrades. Cells become less responsive to growth signals, inflammation becomes chronic rather than acute, and the balance between tissue building and tissue breakdown shifts decisively toward breakdown.

The Regenerative Insight

Regenerative aesthetics addresses aging at this communication level. Rather than adding external structure (fillers) or removing damaged tissue (lasers), regenerative treatments restore the signaling environment that aging has degraded. The goal is to reawaken dormant biological processes and give aging cells the molecular instructions they need to resume producing collagen, elastin, and healthy new tissue.

Platelet-Rich Plasma (PRP): The Established Foundation

PRP therapy, popularly known as the "Vampire Facial" when combined with microneedling, represents the first generation of regenerative aesthetics and remains its most established treatment.

How PRP Works

The PRP procedure begins with a simple blood draw, typically 10-60 mL depending on the treatment area. The blood is placed in a centrifuge, which separates it into three layers: red blood cells, platelet-poor plasma, and platelet-rich plasma. The concentrated platelet layer, which contains three to seven times the normal platelet concentration, is then isolated and either injected directly into the skin or applied topically following microneedling [2].

Platelets are not merely clotting agents. They are rich reservoirs of growth factors, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-B), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF). When these concentrated growth factors are introduced into the skin, they trigger a cascade of regenerative responses: new collagen synthesis, new blood vessel formation, and enhanced cellular turnover [3].

Clinical Evidence for PRP

The American Academy of Dermatology notes that PRP shows promise for facial rejuvenation, though it acknowledges that extensive large-scale studies are still needed [3]. Individual clinical reports and smaller studies have demonstrated improvements in skin texture, fine lines, and overall skin quality following PRP treatments, with results typically becoming visible within two to four weeks and continuing to improve over three to six months.

PRP's safety profile is one of its strongest attributes. Because the treatment uses the patient's own blood, the risk of allergic reaction or rejection is essentially zero. Side effects are generally limited to temporary redness, swelling, and bruising at injection or microneedling sites.

PRP Combined with Microneedling: The Vampire Facial

The most popular PRP application in aesthetics is the "Vampire Facial," which combines PRP with microneedling. The microneedling device creates thousands of microscopic channels in the skin, and PRP is applied topically so that growth factors penetrate into the dermis through these channels. This combination leverages both the collagen-induction benefits of microneedling and the growth-factor stimulation of PRP [2].

Cleveland Clinic describes the mechanism: growth factors in the plasma stimulate the release of skin stem cells, essentially tricking the skin into believing it has been injured so it heals itself with new tissue, including new collagen, new blood vessels, and new cells [2].

Treatment longevity for PRP typically ranges from three to six months, with many practitioners recommending a series of three treatments spaced four to six weeks apart for optimal results, followed by annual maintenance sessions.

The Evolution to PRF

Platelet-rich fibrin (PRF) represents the next evolution of platelet-based therapy. Unlike PRP, which uses anticoagulants during processing, PRF is produced without additives, resulting in a fibrin matrix that releases growth factors more slowly over a longer period. This sustained-release mechanism may provide longer-lasting results, though comparative studies between PRP and PRF are still accumulating [4].

Exosome Therapy: The Cutting Edge

If PRP represents the first generation of regenerative aesthetics, exosomes represent the frontier. These microscopic extracellular vesicles are generating enormous excitement in both clinical practice and research.

What Are Exosomes?

Exosomes are nanoscale vesicles (30-150 nanometers in diameter) naturally secreted by virtually all cell types. They carry a cargo of proteins, lipids, mRNA, and microRNA that facilitates intercellular communication. Think of them as biological text messages -- tiny packages of instructions that cells send to each other to coordinate repair, regeneration, and maintenance [5].

In the context of aesthetics, the most relevant exosomes are those derived from stem cells, particularly mesenchymal stem cells (MSCs) from sources including adipose (fat) tissue, bone marrow, and umbilical cord. These stem cell-derived exosomes carry potent regenerative signals that can induce collagen formation, enhance tissue regeneration, reduce inflammation, and suppress matrix metalloproteinases (the enzymes that break down collagen) [5].

How Exosome Treatments Work

In aesthetic practice, exosomes are typically applied topically following microneedling or delivered via injection. The microneedling approach is most common: a microneedling device creates microchannels in the skin, and an exosome solution is applied immediately afterward, allowing the vesicles to penetrate into the dermis where they can deliver their regenerative cargo directly to fibroblasts and other target cells [1].

The combination of microneedling and exosomes creates a synergistic effect. Microneedling triggers the wound-healing cascade (inflammation, proliferation, remodeling), and exosomes amplify and direct that cascade toward optimal regenerative outcomes. The exosomes essentially provide the cells with a blueprint for how to repair and rejuvenate, accelerating and improving the quality of the healing response.

Clinical Evidence for Exosomes

The clinical evidence base for exosomes in aesthetics is growing rapidly, with several notable studies published in peer-reviewed journals.

A comparative study of 28 individuals found that application of human adipose stem cell-derived exosomes with microneedling significantly improved skin aesthetics over microneedling alone following 12 weeks of treatment. The exosome group showed superior improvements in collagen content, wrinkle reduction, elasticity, hydration, and pigmentation [6].

A six-week clinical trial involving 56 participants using a topically applied serum containing human platelet-derived exosomes showed significantly improved skin health, with measurable reductions in redness, wrinkles, and melanin production [6].

One particularly compelling case study demonstrated that a short protocol of topical exosomes with superficial microneedling achieved durable improvements in pore size, redness, and pigmentation that persisted for nearly two years (21 months) without retreatment [7]. This exceptional durability suggests that exosomes may fundamentally alter the skin's regenerative capacity rather than merely providing temporary improvement.

A systematic review published in Cureus concluded that exosome-based therapies consistently demonstrated significant improvements in skin elasticity, wrinkle depth reduction, enhanced hydration, and pigmentation modulation. The molecular evidence supporting these clinical outcomes included increased collagen and elastin synthesis, reduced oxidative stress, and suppression of matrix metalloproteinases [6].

Exosome Sources and Formulations

Not all exosomes are created equal. The source of exosomes significantly affects their regenerative properties:

Adipose-derived stem cell exosomes are among the most studied and have demonstrated robust anti-aging effects, including collagen stimulation and anti-inflammatory activity.

Platelet-derived exosomes leverage the same growth factor profiles found in PRP but in a more concentrated, cell-free format that may offer advantages in terms of consistency and shelf stability.

Plant-derived exosomes from sources such as aloe vera, ginger, and grape are emerging in the cosmeceutical space, though their efficacy data is more limited compared to human-derived sources.

Milk-derived exosomes represent another emerging category with preliminary evidence of skin-health benefits and favorable safety profiles [6].

The Regulatory Landscape

A critical caveat for consumers and providers: there are currently no FDA-approved exosome products designed for skincare or cosmeceutical applications [5]. Exosomes remain under regulatory review, with significant questions surrounding sourcing, processing consistency, and quality control. Variability among suppliers impacts both efficacy and safety, making it essential that consumers receive exosome treatments only from reputable providers using well-characterized products from established manufacturers.

The FDA issued a warning in 2019 about unapproved exosome products being marketed for various conditions, and the agency continues to monitor the space. This regulatory ambiguity means that while exosome therapy holds tremendous promise, consumers should exercise informed caution and select providers who are transparent about their product sourcing and clinical protocols.

Polynucleotides: The Third Pillar

Polynucleotides (PN) and polydeoxyribonucleotides (PDRN) represent the third major category of regenerative aesthetics. These DNA-fragment-based treatments, best known by brand names like Rejuran and Nucleadyn, have been widely used in South Korea for years and are now entering the global market with considerable momentum.

Mechanism of Action

PDRN consists of DNA fragments derived from salmon sperm (or in some formulations, from other marine sources). When injected into the skin, these DNA fragments activate the adenosine A2A receptor pathway, which triggers a cascade of anti-inflammatory and regenerative responses. The fragments serve as building blocks that fibroblasts can use to accelerate DNA repair and collagen synthesis, and they stimulate the salvage pathway of nucleotide synthesis, effectively providing cells with the raw materials for regeneration [1].

Clinical Applications

PDRN treatments are typically administered via microinjection across the treatment area, often in a grid pattern. The procedure requires minimal downtime, with most patients experiencing only mild redness and swelling for one to two days. Results develop gradually over four to eight weeks as collagen remodeling occurs, with improvements in skin hydration, texture, radiance, and fine lines.

A typical treatment protocol involves three to four sessions spaced two to four weeks apart, with results lasting six to twelve months. Many practitioners in 2026 are combining PDRN with PRP or exosomes for synergistic effects.

Combination Protocols: The Future of Treatment Design

The most exciting developments in regenerative aesthetics involve combining multiple biological therapies for synergistic effects. Rather than choosing between PRP, exosomes, or polynucleotides, progressive practitioners are designing layered protocols that leverage the distinct mechanisms of each [1].

RF Microneedling + PRP

Radiofrequency (RF) microneedling combined with PRP represents one of the most popular combination approaches. The RF energy creates controlled thermal injury in the dermis, triggering robust collagen remodeling, while PRP provides the growth factors needed to optimize the quality and speed of that remodeling process.

Microneedling + Exosomes + PDRN

Some practitioners are now layering exosomes and PDRN following microneedling, reasoning that exosomes provide the signaling instructions for regeneration while PDRN provides the DNA building blocks needed to execute those instructions. Though formal clinical trials comparing these specific combinations are limited, the biological rationale is sound and early clinical reports are encouraging.

Sequential and Maintenance Protocols

Leading aesthetic physicians are designing sequential protocols where patients receive different regenerative treatments at each visit, optimizing different aspects of skin biology with each session. For example, a treatment series might begin with PRP for growth factor stimulation, follow with exosomes for cellular communication enhancement, and conclude with PDRN for tissue repair and consolidation.

Safety Considerations and Risk Profile

Regenerative aesthetics generally offers a favorable safety profile compared to many traditional cosmetic procedures, but patients should be aware of important considerations.

PRP Safety

PRP has the strongest safety track record of the regenerative therapies, largely because it is autologous (derived from the patient's own blood). The primary risks are those associated with the delivery method: bruising, swelling, and infection risk from needles or microneedling devices. Proper sterile technique during blood draw and processing is essential to prevent contamination.

Exosome Safety

Treatments derived from adipose stem cells, platelets, plants, and milk have exhibited favorable safety profiles with minimal adverse events and high patient satisfaction in published studies [6]. However, the lack of FDA regulation means that product quality can vary significantly between manufacturers. Consumers should ensure their provider uses exosomes from established, GMP-certified (Good Manufacturing Practice) sources.

PDRN Safety

PDRN has a strong safety record in its country of origin (South Korea) based on years of clinical use. The primary risks are injection-site reactions, and allergic responses are rare given the highly purified nature of the DNA fragments. However, patients with known allergies to fish or marine products should inform their provider before treatment.

Who Is a Good Candidate for Regenerative Aesthetics?

Regenerative treatments are not universally appropriate, and understanding candidacy is important for setting realistic expectations.

Ideal Candidates

The best candidates for regenerative aesthetic treatments are individuals who meet several criteria. They are generally healthy with no active infections, autoimmune disorders, or blood-clotting abnormalities that could complicate PRP processing. They have early to moderate signs of aging -- fine lines, mild laxity, dull texture, uneven tone -- rather than severe structural aging that might better respond to surgical intervention or volumizing fillers.

Ideal candidates also have realistic expectations. Regenerative treatments produce gradual, natural-looking improvement over weeks to months, not the immediate transformation that fillers or neurotoxins provide. Patients who understand this timeline and are willing to commit to a treatment series consistently report higher satisfaction.

Age-wise, regenerative aesthetics has a broad window of applicability. Patients in their 30s and early 40s may use these treatments preventively, maintaining skin quality before significant collagen loss occurs. Patients in their 50s, 60s, and beyond can achieve meaningful improvement, though they may require more intensive protocols (additional sessions, combination approaches) to compensate for the natural decline in regenerative capacity.

Who Should Proceed with Caution

Certain conditions warrant careful evaluation before pursuing regenerative treatments:

Pregnant or breastfeeding individuals should avoid PRP, exosome, and PDRN treatments, as safety data in this population is insufficient.
Patients on blood thinners (warfarin, aspirin, certain supplements) may have complications with PRP blood draws and should consult their physician.
Active skin infections (bacterial, viral, or fungal) in the treatment area are absolute contraindications -- treatment must wait until the infection resolves.
Autoimmune conditions affecting the skin (lupus, psoriasis in active flare) require careful assessment, as the immune-modulating effects of regenerative treatments could theoretically exacerbate these conditions.
History of keloid scarring requires caution with microneedling-based delivery methods, as the controlled injury could trigger keloid formation in predisposed individuals.

Regenerative Aesthetics vs. Traditional Anti-Aging: A Comparison

Understanding how regenerative treatments compare to established anti-aging modalities helps patients and providers design optimal treatment plans.

Regenerative vs. Neurotoxins (Botox)

Neurotoxins work by temporarily paralyzing muscles that create dynamic wrinkles (crow's feet, forehead lines, frown lines). They are fast-acting (results in three to seven days), predictable, and require no downtime. However, they address only one dimension of aging (muscle-driven wrinkles) and must be repeated every three to four months.

Regenerative treatments address skin quality at a deeper level -- collagen density, hydration, elasticity, texture -- but they do not affect muscle-driven wrinkles. Most patients benefit from combining both approaches: neurotoxins for expression lines and regenerative treatments for overall skin quality.

Regenerative vs. Dermal Fillers

Fillers restore volume that aging depletes from cheeks, temples, nasolabial folds, and lips. They produce immediate, visible results. Regenerative treatments cannot replicate this volumizing effect, but they improve the skin draping over that volume -- making fillers look more natural and last longer when the surrounding skin is healthier.

An emerging application involves combining fillers with PRP at the time of injection. The PRP growth factors may enhance tissue integration of the filler and improve the quality of overlying skin, though this approach is still being studied.

Regenerative vs. Laser Resurfacing

Laser resurfacing (ablative and non-ablative) remains one of the most effective treatments for significant textural damage, scarring, and advanced photodamage. Regenerative treatments offer a less aggressive alternative for patients who cannot tolerate the downtime of laser resurfacing (five to fourteen days for ablative treatments) or who have skin types at higher risk for post-inflammatory hyperpigmentation from laser.

Increasingly, providers are using regenerative treatments as a complement to laser. Applying PRP or exosomes after fractional laser treatment may accelerate healing, reduce downtime, and enhance the collagen remodeling response initiated by the laser.

Market Trends and Industry Growth

The regenerative aesthetics market is experiencing explosive growth. The global medical spa market, which includes regenerative treatments, is projected to reach $78.23 billion by 2033, growing at a CAGR of 15.77% [8]. Regenerative modalities are among the fastest-growing segments within this market.

The IAPAM (International Association for Physicians in Aesthetic Medicine) identifies regenerative aesthetics as one of the top trends for 2026, noting that exosomes, PRP, and polynucleotides are experiencing a surge in demand driven by consumers seeking natural-looking results with minimal downtime [9].

The exosome-based cosmeceuticals market specifically is projected to see substantial growth as products move through regulatory pathways and more clinical data accumulates [5].

Consumer demand is being driven by a cultural shift toward "batch aging" -- the desire to age naturally and gracefully while using science-backed interventions to maintain skin health, rather than pursuing dramatic cosmetic alterations. Regenerative aesthetics fits this ethos perfectly, offering biological rejuvenation rather than architectural alteration. Social media has amplified this shift, with terms like "skin quality" and "regenerative" becoming increasingly prevalent in beauty discourse, particularly among millennial and Gen Z consumers who will comprise the core of the aesthetic medicine market for decades to come.

What to Expect as a Patient

For consumers considering regenerative aesthetic treatments, here is a practical overview of what to expect.

Consultation

A thorough consultation should include a complete medical history, skin analysis, discussion of goals and expectations, and a clear explanation of which regenerative modality (or combination) is recommended and why. Be wary of providers who recommend exosomes or PRP without first assessing whether you are a good candidate.

Treatment Experience

PRP treatments involve a blood draw followed by 20-30 minutes of processing time while the centrifuge separates your blood components. The actual treatment (injection or microneedling application) takes 30-60 minutes depending on the area. Exosome and PDRN treatments without blood draw are generally quicker.

Discomfort is typically mild to moderate, managed with topical numbing cream applied 30-60 minutes before the procedure. Most patients describe the sensation as a mild prickling or heat.

Recovery

Downtime is minimal for most regenerative treatments. Expect redness and mild swelling for one to three days, similar to a moderate sunburn. Most patients can return to normal activities the following day, though makeup and active skincare products should be avoided for 24-48 hours.

Results Timeline

Initial improvements are often visible within two to four weeks as inflammation resolves and early collagen remodeling begins. Optimal results typically develop over two to three months as new collagen matures and integrates into the dermal architecture. Many patients report that their skin continues to improve for up to six months following treatment.

Cost Considerations

PRP facials typically range from $500 to $1,500 per session. Exosome treatments range from $800 to $2,500 depending on the product used and treatment area. PDRN treatments range from $400 to $1,200 per session. Most practitioners recommend a series of three to four treatments for optimal results, making the total investment considerable but comparable to other premium aesthetic treatments.

The Future of Regenerative Aesthetics

The trajectory of regenerative aesthetics points toward increasingly personalized, biologically sophisticated treatments.

Personalized Exosome Formulations

Researchers are exploring the possibility of creating patient-specific exosome formulations derived from the patient's own stem cells, which would combine the autologous safety advantage of PRP with the potent signaling capabilities of exosomes.

AI-Guided Treatment Planning

Artificial intelligence is beginning to play a role in analyzing skin biopsies and imaging data to determine which regenerative modalities will be most effective for each patient's specific aging profile. This data-driven approach promises to move regenerative aesthetics from a one-size-fits-all model to a truly personalized medicine paradigm.

Gene Expression Modulation

The next frontier beyond exosomes may involve direct modulation of gene expression in skin cells using techniques adapted from genetic medicine. While this remains largely theoretical for aesthetic applications, the rapid advances in gene therapy for medical conditions suggest that aesthetically focused gene-expression treatments may arrive sooner than many expect.

Integration with Preventive Medicine

Regenerative aesthetics is increasingly converging with preventive and longevity medicine. The same biological principles that restore aging skin -- growth factor signaling, stem cell activation, DNA repair -- are relevant to whole-body aging. The aesthetic medicine practitioner of the future may function more like an aging-medicine specialist, addressing skin as one component of a comprehensive longevity strategy.

Frequently Asked Questions

What is the difference between PRP, exosomes, and polynucleotides?

PRP (platelet-rich plasma) uses concentrated platelets from your own blood to deliver growth factors that stimulate collagen production and tissue repair. Exosomes are tiny vesicles derived from stem cells that carry regenerative signaling molecules (proteins, RNA) to reprogram aging cells. Polynucleotides (PDRN) are DNA fragments, typically from marine sources, that provide raw building materials for cellular repair and activate anti-inflammatory pathways. Each works through a different biological mechanism, which is why many practitioners combine them for synergistic results. Learn more about specific treatments in our exosome facial guide and vampire facial PRP guide.

Are exosome treatments FDA-approved?

No. As of 2026, there are no FDA-approved exosome products specifically designed for aesthetic or cosmeceutical use. Exosome treatments are offered under the practice of medicine by licensed providers, but the products themselves have not undergone FDA approval. This makes provider selection especially important -- choose practitioners who are transparent about their exosome sourcing, use products from GMP-certified manufacturers, and can discuss the current regulatory landscape honestly. Visit our research section for the latest on regulatory developments.

How many sessions of regenerative treatments do I need?

Most regenerative aesthetic protocols recommend a series of three to four treatments spaced two to six weeks apart for optimal results. PRP treatments are typically spaced four to six weeks apart, exosome treatments three to four weeks apart, and PDRN treatments two to four weeks apart. After the initial series, annual or biannual maintenance sessions are recommended to sustain results. Your provider should customize the treatment frequency based on your specific skin concerns, age, and treatment goals.

Can regenerative treatments replace Botox and fillers?

Regenerative aesthetics and traditional injectables (Botox, fillers) address different aspects of aging and are generally complementary rather than competitive. Botox addresses dynamic wrinkles caused by muscle movement, while fillers restore volume loss. Regenerative treatments improve skin quality, texture, hydration, and collagen density. Many patients use all three approaches as part of a comprehensive anti-aging strategy. That said, patients who achieve significant improvements in skin quality through regenerative treatments may find they need less filler or can extend the interval between Botox appointments. Use our treatment finder to explore what combination might work for your goals.

What are the risks of regenerative aesthetic treatments?

Regenerative treatments generally carry lower risks than surgical procedures or aggressive resurfacing treatments. PRP's primary risk is minimal because it uses your own blood; side effects are limited to temporary redness, swelling, and bruising. Exosome treatments have shown favorable safety profiles in clinical studies, though the unregulated market means product quality can vary. The main risks across all regenerative modalities include infection (mitigated by proper sterile technique), allergic reaction (rare, especially with autologous treatments), and unsatisfactory results. The most significant risk may be receiving substandard products from providers who do not properly vet their exosome sources.

References

World Academy of Cosmetic Surgery. "The Science Behind Regenerative Aesthetics: How PRP and Exosomes Are Transforming Cosmetic Procedures in 2025." December 2025. https://waocs.org/2025/12/25/the-science-behind-regenerative-aesthetics-how-prp-and-exosomes-are-transforming-cosmetic-procedures-in-2025/
Cleveland Clinic. "Vampire Facelift (Platelet-Rich Plasma Facelift)." https://my.clevelandclinic.org/health/procedures/vampire-facelift
American Academy of Dermatology. "Is platelet-rich plasma the secret to younger-looking skin?" https://www.aad.org/public/cosmetic/younger-looking/platelet-rich-plasma-secret-to-younger-skin
Oak Family Dental. "Vampire Facials (PRP) Versus PRF." https://oakfamilydental.com/vampire-facials-prp-versus-prf/
Bioinformant. "The Rise of Exosome-Based Cosmeceuticals in 2026." https://bioinformant.com/exosome-based-cosmeceuticals-market/
Cureus. "Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies." https://www.cureus.com/articles/467420-efficacy-of-exosome-based-therapies-for-skin-rejuvenation-a-systematic-review-of-human-studies
PubMed. "Regenerative Skin Remodeling through Exosome-Based Therapy: A Case Study Demonstrating 21-Month Sustained Outcomes." https://pubmed.ncbi.nlm.nih.gov/40770125/
Grand View Research. "Medical Spa Market Size And Share | Industry Report, 2033." https://www.grandviewresearch.com/industry-analysis/medical-spa-market
IAPAM. "Top Aesthetic Medicine Trends to Watch in 2026." https://iapam.com/2026-aesthetic-medicine-trends
PMC/NIH. "Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders." https://pmc.ncbi.nlm.nih.gov/articles/PMC10296902/

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Regenerative aesthetic treatments should be administered by licensed medical professionals. The FDA has not approved exosome products for cosmeceutical use. Individual results vary based on age, skin condition, treatment protocol, and provider expertise. SpaLens may earn a commission from products or services mentioned in this article. For full details, see our Terms & Conditions.

-- The SpaLens Team